Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic Saline and Dextran for Traumatic Hypovolemic Shock
NCT00316017Phase 3Terminated
- Sponsor
- University of Washington
- Start
- May 2006
- Primary completion
- Aug 2009
- Modality
- Polymer-based Nanoparticles, Device-based Delivery, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of hypertonic saline, dextran-70 in hypovolemic shock, Traumatic shock, sponsored by University of Washington. Started May 2006; status: terminated.
02
Drugs
hypertonic salinedextran-70
03
Conditions
hypovolemic shockTraumatic shock
Beyond the preview
Go deeper on NCT00316017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316017.